(INGR) Ingredion - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US4571871023
Stock: Sweeteners, Starches, Corn Oil, Gluten Feed, Biomaterials
Total Rating 40
Risk 96
Buy Signal -1.18
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.59% |
| Yield on Cost 5y | 4.31% |
| Yield CAGR 5y | 5.70% |
| Payout Consistency | 97.8% |
| Payout Ratio | 29.1% |
| Risk 5d forecast | |
|---|---|
| Volatility | 18.9% |
| Relative Tail Risk | -9.60% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.35 |
| Alpha | -11.56 |
| Character TTM | |
|---|---|
| Beta | 0.306 |
| Beta Downside | 0.241 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.95% |
| CAGR/Max DD | 0.31 |
Description: INGR Ingredion January 06, 2026
Ingredion Incorporated (NYSE: INGR) manufactures and markets a broad portfolio of corn-derived ingredients-including sweeteners, starches, nutrition ingredients, and biomaterial solutions-serving food & beverage, paper, textile, construction, pharmaceutical, and specialty chemical markets worldwide.
Key operating metrics that investors watch include the company’s FY 2024 revenue of roughly $6.3 billion, an adjusted EBITDA margin near 12 %, and a free-cash-flow conversion rate of ~80 % of EBITDA, reflecting strong cash generation. The business is highly sensitive to corn commodity prices and global food-security trends; a 10 % rise in corn costs historically depresses gross margins by ~0.5 %-0.7 % while rising demand for plant-based proteins and biodegradable plastics offers a secular growth tailwind.
For a deeper dive into Ingredion’s valuation dynamics and peer comparison, you may find ValueRay’s analytical tools useful.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 729.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA -5.00 > 1.0 |
| NWC/Revenue: 30.32% < 20% (prev 27.91%; Δ 2.41% < -1%) |
| CFO/TA 0.12 > 3% & CFO 944.0m > Net Income 729.0m |
| Net Debt (760.0m) to EBITDA (1.23b): 0.62 < 3 |
| Current Ratio: 2.66 > 1.5 & < 3 |
| Outstanding Shares: last quarter (64.4m) vs 12m ago -3.16% < -2% |
| Gross Margin: 25.32% > 18% (prev 0.24%; Δ 2508 % > 0.5%) |
| Asset Turnover: 94.11% > 50% (prev 99.81%; Δ -5.70% > 0%) |
| Interest Coverage Ratio: 27.32 > 6 (EBITDA TTM 1.23b / Interest Expense TTM 37.0m) |
Altman Z'' 6.41
| A: 0.28 (Total Current Assets 3.50b - Total Current Liabilities 1.32b) / Total Assets 7.90b |
| B: 0.71 (Retained Earnings 5.61b / Total Assets 7.90b) |
| C: 0.13 (EBIT TTM 1.01b / Avg Total Assets 7.67b) |
| D: 1.32 (Book Value of Equity 4.67b / Total Liabilities 3.53b) |
| Altman-Z'' Score: 6.41 = AAA |
Beneish M -3.04
| DSRI: 1.12 (Receivables 1.19b/1.09b, Revenue 7.22b/7.43b) |
| GMI: 0.95 (GM 25.32% / 24.10%) |
| AQI: 0.96 (AQ_t 0.24 / AQ_t-1 0.25) |
| SGI: 0.97 (Revenue 7.22b / 7.43b) |
| TATA: -0.03 (NI 729.0m - CFO 944.0m) / TA 7.90b) |
| Beneish M-Score: -3.04 (Cap -4..+1) = AA |
What is the price of INGR shares?
As of February 10, 2026, the stock is trading at USD 119.29 with a total of 702,271 shares traded.
Over the past week, the price has changed by +1.69%, over one month by +5.04%, over three months by +11.87% and over the past year by -4.01%.
Over the past week, the price has changed by +1.69%, over one month by +5.04%, over three months by +11.87% and over the past year by -4.01%.
Is INGR a buy, sell or hold?
Ingredion has received a consensus analysts rating of 3.43.
Therefor, it is recommend to hold INGR.
- StrongBuy: 1
- Buy: 1
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the INGR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 124.3 | 4.2% |
| Analysts Target Price | 124.3 | 4.2% |
| ValueRay Target Price | 129.9 | 8.9% |
INGR Fundamental Data Overview February 05, 2026
P/E Trailing = 11.6903
P/E Forward = 10.3842
P/S = 1.0642
P/B = 1.7465
P/EG = 1.2365
Revenue TTM = 7.22b USD
EBIT TTM = 1.01b USD
EBITDA TTM = 1.23b USD
Long Term Debt = 1.74b USD (from longTermDebt, two quarters ago)
Short Term Debt = 48.0m USD (from shortTermDebt, last quarter)
Debt = 1.79b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 760.0m USD (from netDebt column, last quarter)
Enterprise Value = 8.49b USD (7.73b + Debt 1.79b - CCE 1.03b)
Interest Coverage Ratio = 27.32 (Ebit TTM 1.01b / Interest Expense TTM 37.0m)
EV/FCF = 10.49x (Enterprise Value 8.49b / FCF TTM 809.0m)
FCF Yield = 9.53% (FCF TTM 809.0m / Enterprise Value 8.49b)
FCF Margin = 11.21% (FCF TTM 809.0m / Revenue TTM 7.22b)
Net Margin = 10.10% (Net Income TTM 729.0m / Revenue TTM 7.22b)
Gross Margin = 25.32% ((Revenue TTM 7.22b - Cost of Revenue TTM 5.39b) / Revenue TTM)
Gross Margin QoQ = 24.47% (prev 25.06%)
Tobins Q-Ratio = 1.07 (Enterprise Value 8.49b / Total Assets 7.90b)
Interest Expense / Debt = 0.50% (Interest Expense 9.00m / Debt 1.79b)
Taxrate = 19.32% (40.0m / 207.0m)
NOPAT = 815.6m (EBIT 1.01b * (1 - 19.32%))
Current Ratio = 2.66 (Total Current Assets 3.50b / Total Current Liabilities 1.32b)
Debt / Equity = 0.41 (Debt 1.79b / totalStockholderEquity, last quarter 4.34b)
Debt / EBITDA = 0.62 (Net Debt 760.0m / EBITDA 1.23b)
Debt / FCF = 0.94 (Net Debt 760.0m / FCF TTM 809.0m)
Total Stockholder Equity = 4.23b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.50% (Net Income 729.0m / Total Assets 7.90b)
RoE = 17.25% (Net Income TTM 729.0m / Total Stockholder Equity 4.23b)
RoCE = 16.94% (EBIT 1.01b / Capital Employed (Equity 4.23b + L.T.Debt 1.74b))
RoIC = 13.65% (NOPAT 815.6m / Invested Capital 5.98b)
WACC = 5.79% (E(7.73b)/V(9.52b) * Re(7.04%) + D(1.79b)/V(9.52b) * Rd(0.50%) * (1-Tc(0.19)))
Discount Rate = 7.04% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -1.52%
[DCF Debug] Terminal Value 83.75% ; FCFF base≈939.4m ; Y1≈750.5m ; Y5≈507.3m
Fair Price DCF = 233.5 (EV 15.60b - Net Debt 760.0m = Equity 14.84b / Shares 63.5m; r=5.90% [WACC]; 5y FCF grow -24.05% → 2.90% )
EPS Correlation: 69.21 | EPS CAGR: 7.19% | SUE: -0.48 | # QB: 0
Revenue Correlation: -78.80 | Revenue CAGR: -1.95% | SUE: -0.77 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.78 | Chg30d=-0.013 | Revisions Net=-2 | Analysts=4
EPS current Year (2026-12-31): EPS=11.50 | Chg30d=-0.040 | Revisions Net=-2 | Growth EPS=+3.3% | Growth Revenue=+1.8%
EPS next Year (2027-12-31): EPS=12.00 | Chg30d=+0.071 | Revisions Net=-2 | Growth EPS=+4.4% | Growth Revenue=+1.3%
P/E Forward = 10.3842
P/S = 1.0642
P/B = 1.7465
P/EG = 1.2365
Revenue TTM = 7.22b USD
EBIT TTM = 1.01b USD
EBITDA TTM = 1.23b USD
Long Term Debt = 1.74b USD (from longTermDebt, two quarters ago)
Short Term Debt = 48.0m USD (from shortTermDebt, last quarter)
Debt = 1.79b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 760.0m USD (from netDebt column, last quarter)
Enterprise Value = 8.49b USD (7.73b + Debt 1.79b - CCE 1.03b)
Interest Coverage Ratio = 27.32 (Ebit TTM 1.01b / Interest Expense TTM 37.0m)
EV/FCF = 10.49x (Enterprise Value 8.49b / FCF TTM 809.0m)
FCF Yield = 9.53% (FCF TTM 809.0m / Enterprise Value 8.49b)
FCF Margin = 11.21% (FCF TTM 809.0m / Revenue TTM 7.22b)
Net Margin = 10.10% (Net Income TTM 729.0m / Revenue TTM 7.22b)
Gross Margin = 25.32% ((Revenue TTM 7.22b - Cost of Revenue TTM 5.39b) / Revenue TTM)
Gross Margin QoQ = 24.47% (prev 25.06%)
Tobins Q-Ratio = 1.07 (Enterprise Value 8.49b / Total Assets 7.90b)
Interest Expense / Debt = 0.50% (Interest Expense 9.00m / Debt 1.79b)
Taxrate = 19.32% (40.0m / 207.0m)
NOPAT = 815.6m (EBIT 1.01b * (1 - 19.32%))
Current Ratio = 2.66 (Total Current Assets 3.50b / Total Current Liabilities 1.32b)
Debt / Equity = 0.41 (Debt 1.79b / totalStockholderEquity, last quarter 4.34b)
Debt / EBITDA = 0.62 (Net Debt 760.0m / EBITDA 1.23b)
Debt / FCF = 0.94 (Net Debt 760.0m / FCF TTM 809.0m)
Total Stockholder Equity = 4.23b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.50% (Net Income 729.0m / Total Assets 7.90b)
RoE = 17.25% (Net Income TTM 729.0m / Total Stockholder Equity 4.23b)
RoCE = 16.94% (EBIT 1.01b / Capital Employed (Equity 4.23b + L.T.Debt 1.74b))
RoIC = 13.65% (NOPAT 815.6m / Invested Capital 5.98b)
WACC = 5.79% (E(7.73b)/V(9.52b) * Re(7.04%) + D(1.79b)/V(9.52b) * Rd(0.50%) * (1-Tc(0.19)))
Discount Rate = 7.04% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -1.52%
[DCF Debug] Terminal Value 83.75% ; FCFF base≈939.4m ; Y1≈750.5m ; Y5≈507.3m
Fair Price DCF = 233.5 (EV 15.60b - Net Debt 760.0m = Equity 14.84b / Shares 63.5m; r=5.90% [WACC]; 5y FCF grow -24.05% → 2.90% )
EPS Correlation: 69.21 | EPS CAGR: 7.19% | SUE: -0.48 | # QB: 0
Revenue Correlation: -78.80 | Revenue CAGR: -1.95% | SUE: -0.77 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.78 | Chg30d=-0.013 | Revisions Net=-2 | Analysts=4
EPS current Year (2026-12-31): EPS=11.50 | Chg30d=-0.040 | Revisions Net=-2 | Growth EPS=+3.3% | Growth Revenue=+1.8%
EPS next Year (2027-12-31): EPS=12.00 | Chg30d=+0.071 | Revisions Net=-2 | Growth EPS=+4.4% | Growth Revenue=+1.3%